Nexentis Technologies Inc. (NXTS) stock
Close on Nov 12, 2026Market cap $2.92MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $2.92M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.53
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$16.03M
- EPS, diluted
- -$8.61
- Free cash flow
- -$3.82M
- Book value per share
- $2.33
- Diluted shares
- 1M
Trading
- Previous close
- $2.30
- Open
- $2.20
- Day's range
- $1.93 – $2.20
- Volume
- 35,529
- Average volume (20 days)
- 56,010
- Beta (5 years)
- 0.30
- 52-week range
- $1.93 – $119.00
- RSI (14 days)
- 24.5
- Volatility (1 year)
- 203.4%
- Relative volume
- 0.56×
- WACC
- 7.2%
Market cap history
Month-end market cap since 2021, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | NXTS | S&P 500 | Difference | NXTS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -47.1% | -2.7% | −44.4 pts | ||
| 3 months | -78.2% | -1.7% | −76.4 pts | ||
| Year to date | -96.6% | +11.9% | −108.5 pts | ||
| 1 year | -98.2% | +12.0% | −110.2 pts | ||
| 3 years | -99.9% | +78.2% | −178.1 pts | -91.2% | +21.2% |
| 5 years | -100.0% | +73.2% | −173.2 pts | -87.4% | +11.6% |
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Nexentis Technologies filed with the SEC as exhibits to Form 8-K or 6-K
- News
- Update
- News
- News
- News
- News
About Nexentis Technologies
Pharmaceutical Preparations
Nexentis Technologies, Inc. is a corporate entity engaged in biotechnology activities and renewable energy projects. Through its operating segments, the company participates in agricultural and life science ventures, including collaborations and investments associated with Save Foods Ltd., Plantify Foods, and MitoCareX Bio Ltd. Additionally, the business focuses on clean energy initiatives through solar photovoltaic joint ventures and partnership arrangements involving Solterra Renewable Energy Ltd., serving commercial, technological, and agricultural markets.
Company profile, executives and historyNexentis Technologies stock: common questions
What is Nexentis Technologies's stock price?
NXTS closed at $2.01 on Nov 12, 2026, down 12.61% on the day. Over the past 52 weeks it traded between $1.93 and $119.00.
What is Nexentis Technologies's market cap?
Nexentis Technologies was worth $2.92M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is NXTS's P/E ratio?
Nexentis Technologies lost money over fiscal 2025 (diluted EPS -$8.61), so it has no meaningful P/E ratio.
Does Nexentis Technologies pay a dividend?
No. Nexentis Technologies has not paid a cash dividend over the last twelve months.
How has NXTS stock performed over the past year?
Including dividends, NXTS returned -98.2% over the past year, against +12.0% for the S&P 500.
Who are Nexentis Technologies's competitors?
Companies most similar to Nexentis Technologies by business, industry and size include LEXX, XTLB, CLNN, GDTC, RDHL.
See a number that looks wrong?